Impel Pharmaceuticals

IPO

Impel Pharmaceuticals is a biotech company in Keller, United States, founded in 2008. It has raised $148.5M across 4 rounds, most recently a $45.0M Corporate Round in September 2021.

Headquarters
Keller, Texas
Employees
51–200
Founded
2008
Business Model
B2B2C
Total Funding
$148.5M
Last Round
$45.0M Corporate RoundSep 2021
Rounds
4
Type
Public

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 4 funding rounds and 4 investors for this company. The full record is or through the API.

About

Impel Pharmaceuticals is a commercial-stage pharmaceutical company pioneering Precision Olfactory Delivery (POD) technology. It administers drug formulations deep into the vascular-rich upper nasal space to improve onset of symptomatic relief for CNS diseases including migraine and Alzheimer's, addressing conditions with high unmet medical needs.

Summary

It lists 51–200 employees. It has raised $148.5M in total across 4 rounds, most recently a $45.0M Corporate Round in Sep 2021. Investors include Norwest Venture Partners, KKR and 5AM Ventures.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding & Exit History

Data from Indexed.vcUpdated
Corporate RoundCorporate RoundSep 2021
$45.0M

Sign up to see all 5 events

Funding: Venture Round through Corporate Round. Amounts, valuations, and investors where available.

Investors

Similar Companies

Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
BridgeBioIPO

BridgeBio develops treatments for genetic conditions through autonomous condition-focused teams s...

San Francisco Bay Area, United States201–500Biotech, Healthcare
Growth EquityTotal funding$2.7BJul 2026
AsymchemIPO

Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...

Tianjin, China5001–10000Biotech, Drug Discovery
Private EquityTotal funding$2.3BFeb 2020
Calico

Calico researches human aging using advanced technologies and model systems, applying that knowle...

South San Francisco, United States201–500Biotech, Healthcare
Corporate RoundTotal funding$2.3BJun 2018
Sana BiotechnologyIPO

Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...

Seattle, United States201–500Biotech, Healthcare
Series DTotal funding$1.4BJun 2020
CertaraIPO

Global biosimulation software and services company accelerating drug development for 2,000+ bioph...

Radnor, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$1.3BDec 2022

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Impel Pharmaceuticals on Indexed.vc
<a href="https://indexed.vc/companies/impel-pharmaceuticals"><img src="https://indexed.vc/api/badge/company/impel-pharmaceuticals" alt="Impel Pharmaceuticals on Indexed.vc" width="260" height="76" /></a>